CPAP devices market to grow by $1.33b by 2028

It is driven by the rising prevalence of sleep apnea and respiratory disorders.

The global continuous positive airway pressure (CPAP) devices market is projected to increase by $1.33b from 2024 to 2028, with a compound annual growth rate (CAGR) of about 6.35%. 

This growth is driven by the rising prevalence of sleep apnea and respiratory disorders, as well as an increase in partnerships between medical technology companies.

The demand for CPAP devices is increasing, particularly amongst the aging population, as these devices are effective for treating sleep disorders like Obstructive Sleep Apnea and Hypopnea Syndrome. 

The devices are increasingly used in both hospital and home care settings, addressing health risks related to cardiovascular diseases. 

Innovations such as mandibular advancing devices and heated humidifiers are enhancing patient comfort, whilst reimbursement policies and telemedicine are facilitating home-based treatments.

However, the market faces challenges, including contamination risks and product recalls due to safety concerns.

As the market grows, addressing patient comfort and ensuring effective home care will be crucial. The prevalence of comorbidities, such as obesity and hypertension, continues to increase the demand for CPAP devices, which are essential for reducing mortality risks associated with respiratory disorders and improving life expectancy.